These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12240748)

  • 1. Growth curve analyses of neuropsychological profiles in children with neurofibromatosis type 1: specific cognitive tests remain "spared" and "impaired" over time.
    Cutting LE; Huang GH; Zeger S; Koth CW; Thompson RE; Denckl MB
    J Int Neuropsychol Soc; 2002 Sep; 8(6):838-46. PubMed ID: 12240748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1: the cognitive phenotype.
    Hofman KJ; Harris EL; Bryan RN; Denckla MB
    J Pediatr; 1994 Apr; 124(4):S1-8. PubMed ID: 8151460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited.
    Cutting LE; Koth CW; Denckla MB
    Dev Neuropsychol; 2000; 17(1):29-47. PubMed ID: 10916573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
    Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
    Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive profile of preschool-aged children with neurofibromatosis type 1.
    Sangster J; Shores EA; Watt S; North KN
    Child Neuropsychol; 2011; 17(1):1-16. PubMed ID: 20503125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive profile of children with neurofibromatosis and reading disabilities.
    Cutting LE; Levine TM
    Child Neuropsychol; 2010; 16(5):417-32. PubMed ID: 20521183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families.
    Rommelse NN; Altink ME; Oosterlaan J; Buschgens CJ; Buitelaar J; Sergeant JA
    Psychol Med; 2008 Nov; 38(11):1595-606. PubMed ID: 18261248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
    van der Vaart T; Rietman AB; Plasschaert E; Legius E; Elgersma Y; Moll HA;
    Neurology; 2016 Jan; 86(2):154-60. PubMed ID: 26519538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.
    Payne JM; Hyman SL; Shores EA; North KN
    Child Neuropsychol; 2011; 17(4):313-29. PubMed ID: 21347908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Review and Meta-analysis of the Intellectual Integrity of Children with Neurofibromatosis Type 1.
    Al-Farsi FAH; Al-Alyani OBS; Al-Kumzari A; Al-Saadi T
    World Neurosurg; 2022 Jan; 157():69-74. PubMed ID: 34648986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning problems in neurofibromatosis patients.
    Stine SB; Adams WV
    Clin Orthop Relat Res; 1989 Aug; (245):43-8. PubMed ID: 2502350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.
    North K; Joy P; Yuille D; Cocks N; Mobbs E; Hutchins P; McHugh K; de Silva M
    Neurology; 1994 May; 44(5):878-83. PubMed ID: 8190291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.
    Eldridge R; Denckla MB; Bien E; Myers S; Kaiser-Kupfer MI; Pikus A; Schlesinger SL; Parry DM; Dambrosia JM; Zasloff MA
    Am J Dis Child; 1989 Jul; 143(7):833-7. PubMed ID: 2500844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: a preliminary controlled experimental video-EEG case series.
    Iqbal N; Caswell HL; Hare DJ; Pilkington O; Mercer S; Duncan S
    Epilepsy Behav; 2009 Mar; 14(3):516-21. PubMed ID: 19166970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.